Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions [Phase 1]
Phase 1 study completed to assess the relative bioavailability of divalproex sodium 500 mg delayed-release tablets under fed conditions. The…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fasting Conditions [Phase 1]
Phase 1 study evaluating the relative bioavailability of divalproex sodium 500 mg delayed-release tablets under fasting conditions.
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder [Phase 4]
This document reports a Phase 4 open-label extension study of licarbazepine for manic episodes in Bipolar I disorder. The trial has complete…
-
CLINICAL_TRIALS trial_result · 2017-03-28Clinical Trial Update: Circadian Phase in Bipolar Depression: Is it Delayed and Does it Normalize With Remission?
This document reports a completed clinical trial examining circadian phase in bipolar depression. It investigates whether circadian phase is…
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder [Phase 3]
Phase 3 study evaluating licarbazepine for manic episodes in bipolar disorder has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder [Phase 3]
A Phase 3 trial investigating licarbazepine for manic episodes in bipolar disorder has completed enrollment and status is reported as comple…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes [Phase 3]
Phase 3 trial assessing switching between different strength forms of FK949E in bipolar depression; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-16Clinical Trial Update: Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating intranasal ketamine for pediatric bipolar disorder has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Integration of Illness Management and Recovery Within ACT [NA]
A completed clinical trial update describes integrating Illness Management and Recovery within Assertive Community Treatment for individuals…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Simvastatin Augmentation of Lithium Treatment in Bipolar Depression [Phase 2]
This Phase 2 clinical trial update reports results for simvastatin augmentation of lithium in bipolar depression; the study (NCT01665950) wa…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Spot Depression Study
The update notes the completion of the Spot Depression Study (NCT02804867) conducted by the University of Cambridge, investigating treatment…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder [Phase 3]
Phase 3 clinical trial update evaluating licarbazepine for manic episodes in bipolar disorder. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: An Open-label Extension Study to Evaluate the Safety and Tolerability of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder. [Phase 3]
An open-label extension study assessing the safety and tolerability of licarbazepine for manic episodes in Bipolar I Disorder. The update su…
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Insulin Resistance in Patients With Mood Disorder [NA]
This clinical trial update reports completion and posted results of a study exploring insulin resistance in patients with mood disorders, in…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram [Phase 2, Phase 3]
This clinical trial update reports Phase 2 and Phase 3 results for using citalopram to treat acute bipolar depression and to examine prophyl…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder [Phase 4]
Phase 4 study investigating predictors of response to augmentation with ziprasidone (Geodon) in major depressive disorder, with results post…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: An fMRI Study on Temporal Discounting in Bipolar Disorder
This is a completed clinical trial from Massachusetts General Hospital using fMRI to study temporal discounting in individuals with bipolar …
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: A Study to Evaluate the Efficacy of FK949E in Bipolar Disorder Patients With Major Depressive Episodes [Phase 2, Phase 3]
The clinical trial evaluating FK949E for major depressive episodes in bipolar disorder has completed Phase 2 and Phase 3, with results poste…
-
CLINICAL_TRIALS trial_result · 2017-02-02Clinical Trial Update: Lurasidone and Cognition in Bipolar I Disorder [Phase 3]
A Phase 3 study evaluating lurasidone for cognitive outcomes in Bipolar I Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Personal Adherence Evaluation of Medication Use for Adult Bipolar Disorder Patients
A completed clinical trial evaluating how adults with bipolar disorder adhere to their prescribed medications.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: Pioglitazone for the Treatment of Bipolar Depression [Phase 4]
Phase 4 trial evaluating pioglitazone for bipolar depression was terminated. Results were posted on 2017-01-27.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
A completed pilot cohort study assessing how common comorbid mental illness and substance use disorders are, including schizophrenia and rel…
-
CLINICAL_TRIALS trial_result · 2017-01-23Clinical Trial Update: Lamotrigine Phase III Study in Bipolar I Disorder [Phase 3]
This update reports the completion of a Phase 3 trial evaluating lamotrigine in Bipolar Disorder, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Treatment Resistant Depression in Bipolar Disorder - A Randomized Controlled Trial of Electroconvulsive Therapy [NA]
A randomized controlled trial evaluated electroconvulsive therapy for treatment-resistant depression in bipolar disorder; the study has comp…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Open-label Ziprasidone Study for Psychosis Treatment in Adolescents [Phase 3]
This open-label Phase 3 trial evaluated ziprasidone for treating psychosis-related disorders in adolescents, including schizophreniform diso…